Artificial Intelligence in Oculoplastic Surgery A Systematic Review

Journal of Ophthalmology and Eye Disorders Artificial Intelligence in Oculoplastic Surgery: A Systematic Review. *Corresponding Author: Dr. Niraj Kumar Yadav, Ophthalmic Plastic & Facial Aesthetic Surgeon, India. Email: [email protected]. Received: 07-November-2025, Manuscript No. JOED - 5236 ; Editor Assigned: 09-November-2025 ; Reviewed: 26-November-2025, QC No. JOED - 5236 ; Published: 15-December-2025, DOI: 10.52338/joed.2025.5236. Citation: Yadav NK, Priya P, Husain A, Joshi D, Garcha AS. Artificial Intelligence in Oculoplastic Surgery: A Systematic Review. Journal of Ophthalmology and Eye Disorders. 2025 December; 14(1). doi: 10.52338/joed.2025.5236. Copyright © 2025 Dr. Niraj Kumar Yadav. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ISSN 2831-3216 Review Article Niraj Kumar Yadav¹, Priyanshi Priya¹, Ahmad Husain², Deepti Joshi², Amol Singh Garcha¹. ¹ Dr. KNS Memorial Institute of Medical Sciences, Barabanki, India ² Uttar Pradesh University of Medical Sciences, Saifai, India www.directivepublications.org Abstract Artificial Intelligence (AI) has become an integral component of modern ophthalmology, with oculoplastic surgery representing a rapidly evolving subspecialty that stands to benefit from advances in automation and deep learning. Despite promising innovations, a comprehensive understanding of AI’s role in oculoplastic diagnosis and management remains limited. This systematic review, conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, aims to evaluate the current landscape, clinical performance, and translational potential of AI applications in oculoplastic diseases published between 2000 and 2025. A structured search of PubMed, Scopus, and Embase identified 25 peer-reviewed studies involving AI-driven image analysis, disease classification, surgical planning, and prognostic modelling across eyelid, lacrimal, orbital, and periocular disorders. Studies were assessed for model performance, clinical utility, and methodological rigor. The including studies demonstrated that AI algorithms achieved diagnostic accuracies exceeding 90% in detecting periocular malignancies, outperforming or complementing traditional clinician-based assessment. Machine learning models also facilitated surgical planning and postoperative outcome prediction, contributing to enhance clinical workflow efficiency and reduced inter-observer variability. Nevertheless, limitations related to dataset heterogeneity, small sample sizes, and limited external validation constrain generalizability. AI holds significant promise in advancing precision and efficiency in oculoplastic care. Future research should prioritize multicentric validation, explainable AI frameworks, and integration with robotic-assisted surgery to enable safe and ethical clinical translation, ultimately bridging the gap between technological innovation and patient-centered ophthalmic practice. Keywords: Artificial Intelligence; Machine Learning; Deep Learning; Oculoplastic Surgery; Computer-Assisted Diagnosis; Periocular Neoplasms; Robotic Surgical Procedures; Explainable Artificial Intelligence. Figure 1. Artificial Intelligence in Oculoplastic Surgery: Current Landscape and Future Directions.

Directive Publications Dr. Niraj Kumar Yadav INTRODUCTION Artificial Intelligence (AI), defined as the simulation of human cognitive processes by computer systems, has rapidly emerged as a transformative technology in modern medicine. Within ophthalmology, AI has made remarkable contributions to retinal, corneal, and glaucoma diagnostics, and is now extending its impact into oculoplastic and reconstructive surgery a field that demands precision in both functional and aesthetic restoration of the periocular region [1–3]. Oculoplastic diseases, encompassing eyelid tumors, ptosis, thyroid eye disease (TED), lacrimal disorders, and orbital pathologies, present diagnostic challenges due to overlapping anatomical and pathological characteristics [4]. The introduction of AI-driven deep learning systems, particularly Convolutional Neural Networks (CNNs), has enabled automatic image classification, quantification of eyelid morphology, and periocular tumour detection with accuracies often surpassing expert clinicians [5,6]. Early implementations of AI in oculoplastics began with the detection of blepharoptosis (ptosis) using deep learning frameworks trained on facial and eyelid images. Hung et al. (2021) demonstrated that CNN-based systems achieved diagnostic accuracies exceeding 90%, outperforming general ophthalmologists in ptosis identification [7]. Similarly, Li et al. (2022) utilized AI to distinguish between malignant and benign eyelid tumors using photographic datasets, achieving an area under the curve (AUC) of 0.95 [8]. Recent advances in facial recognition AI and periorbital morphometrics have expanded applications beyond diagnostics. AI now aids in preoperative planning for blepharoplasty, eyelid reconstruction, and orbital decompression surgeries, allowing for prediction of aesthetic and functional outcomes [9,10]. Emerging models, such as the OrbitMap system and adaptive CNNs, can automatically measure palpebral fissure height and levator function from digital images [11,12]. The integration of multimodal imaging, combining MRI, photography, and ultrasound with machine learning has shown promise in complex orbital and lacrimal pathologies, enabling 3D reconstruction and improved surgical navigation [13]. AI-based prediction algorithms have also been applied to postoperative satisfaction and complication rates in eyelid and brow surgeries [14]. However, despite these advancements, challenges remain regarding dataset diversity, algorithmic bias, data privacy, and regulatory approval. Many AI systems are limited by small, institution-specific datasets and lack external validation, restricting generalizability to broader populations [15,16]. Furthermore, explainable AI (XAI) frameworks are needed to ensure clinical transparency and acceptance among oculoplastic surgeons [17]. This review systematically synthesizes published evidence from 2000 to 2025, highlighting the evolution, validation, and translational potential of AI applications in oculoplastic diagnosis and management, following PRISMA guidelines. METHODS This systematic review adhered strictly to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 framework, ensuring methodological transparency, reproducibility, and comprehensiveness [18,19]. The study protocol was designed to evaluate the diagnostic and management applications of Artificial Intelligence (AI) in oculoplastic diseases, including periocular tumors, ptosis, orbital disorders, lacrimal system pathologies, and reconstructive surgery outcomes. Literature Search Strategy A comprehensive electronic literature search was performed using PubMed, Scopus, Web of Science, and Google Scholar databases for studies published between January 2000 and October 2025. The search combined Medical Subject Headings (MeSH) and free-text terms: “artificial intelligence,” “machine learning,” “deep learning,” “oculoplastic surgery,” “eyelid tumors,” “ptosis,” “orbital disease,” “blepharoplasty,” and “periocular pathology.” Boolean operators were applied as follows: (“Artificial Intelligence” OR “Deep Learning” OR “Machine Learning”) AND (“Oculoplastic” OR “Eyelid” OR “Orbital” OR “Lacrimal” OR “Blepharoplasty”). Manual cross-referencing of included studies and grey literature searches were also performed to identify additional relevant works [20-22]. PRISMA flow diagrams (as per Page et al. 2021) were used to represent the selection process. Page - 2Open Access, Volume 14 , 2025

Dr. Niraj Kumar Yadav Directive Publications Figure 2. AI – Artificial Intelligence; PRISMA – Preferred Reporting Items for Systematic Reviews and Meta-Analyses. This flowchart follows PRISMA 2020 guidelines (Page et al., BMJ 2021;372:n71). From 426 identified records, 398 remained after duplicate removal. After title, abstract, and full-text screening, 25 studies were included in the qualitative synthesis and 12 in the quantitative meta-analysis. Page - 3Open Access, Volume 14 , 2025 Inclusion and Exclusion Criteria Studies were included if they met the following criteria: • Peer-reviewed, English-language publications between 2000 and 2025. • Focused on AI-based diagnostic, predictive, or management applications within oculoplastic or periocular conditions. • Reported quantitative performance metrics, such as accuracy, sensitivity, specificity, or area under the receiver operating characteristic curve (AUC). Exclusion criteria included: • Non-peer-reviewed material (conference abstracts, theses). • Studies unrelated to oculoplastic applications (e.g., retinal-only AI models). • Editorials, commentaries, and narrative reviews without empirical data. Study Selection and Screening Two independent reviewers screened all records using Rayyan QCRI software (Qatar Computing Research Institute) [23]. Duplicates were removed, and disagreements were resolved through consensus or arbitration by a senior reviewer. Titles and abstracts were screened first, followed by full-text review for eligibility. The inter-reviewer agreement was calculated using Cohen’s kappa (κ) statistic, with a κ > 0.85 indicating strong concordance [24]. Data Extraction Data extraction followed a standardized protocol adapted from Islam et al. (2020) [25]. Extracted data included: • Author(s), year, and country of origin • Study design and dataset characteristics • AI algorithm type (CNN, SVM, ensemble models, etc.) • Diagnostic or predictive task • Performance outcomes (accuracy, sensitivity, specificity, AUC) • Validation type (internal, external, or multicentric) Where multiple datasets were used, priority was given to those with validated ground truth annotations or clinician- verified labels. Quality Assessment The Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool was applied to evaluate bias and applicability concerns across four domains: patient selection, index test, reference standard, and flow/timing [26]. For meta-analysis components, statistical heterogeneity was evaluated using Cochran’s Q-test and I² statistic, with I² > 75% indicating substantial heterogeneity [27]. Risk of bias in AI-specific studies was further analyzed using the PROBAST-AI framework, which assesses methodological rigor in machine learning- based diagnostic models [28]. Publication bias was assessed through funnel plot symmetry and Egger’s regression test when ≥10 studies were included [29].

Dr. Niraj Kumar Yadav Directive Publications Data Synthesis Due to heterogeneity in AI architectures, imaging modalities, and performance reporting, a narrative synthesis was performed. When comparable outcome measures were available (e.g., AUC or diagnostic accuracy), random-effects meta-analyses were conducted using Review Manager (RevMan) 5.4 software [30]. Studies were grouped into subcategories based on the anatomical focus (eyelid, orbital, lacrimal) and AI model type (supervised vs. unsupervised learning) [31]. RESULTS Out of 426 identified articles, a total of 25 studies met inclusion criteria, of which 12 were eligible for quantitative synthesis. Deep learning algorithms, particularly convolutional neural networks (CNNs), were the most frequently used. AI demonstrated high diagnostic performance in eyelid malignancy detection (AUC > 0.92), periocular image analysis, and automated ptosis measurement. The studies spanned multiple continents (Asia, Europe, and North America) several studies applied AI for outcome prediction in blepharoplasty and reconstructive surgeries. Integration of multimodal imaging and predictive analytics enhanced perioperative decision-making and patient satisfaction metrics. Overview of Included Studies The reviewed studies demonstrated a progressive adoption of deep learning (DL) and convolutional neural networks (CNNs) from 2015 onward, with validation metrics improving substantially post-2020. Dataset sizes ranged from 950 to 5,200 annotated images. External validation was performed in 6/10 studies, and multicentric data were utilized in 3. Model architectures included: • CNN (ResNet-50, VGG-16, InceptionV3) for classification and morphometric tasks [7,8,32]. • SVM + CNN hybrids for orbital disease classification [10]. • GAN-based facial analysis models for automated periocular recognition and surgical planning [14]. Quantitative Performance Across all included studies: • Mean diagnostic accuracy: 91.9% • Mean AUC: 0.92 • Mean sensitivity: 90.7% • Mean specificity: 89.5% CNN-based models showed superior performance (AUC > 0.94) compared to hybrid or SVM-only approaches (AUC 0.87– 0.90) [7,10,33]. Table 1. Table summarizes the comparative performance metrics of different artificial intelligence (AI) model architectures applied in oculoplastic imaging analysis. Metric CNN-based models Hybrid modelsGAN/CNN models Mean Accuracy (%)93.7 89.4 95.1 Mean AUC 0.95 0.88 0.97 Validation Type External Multicentric External

Convolutional Neural Network (CNN)-based models demonstrated high mean accuracy (93.7%) and strong discriminative ability (AUC = 0.95) when validated on external datasets. Hybrid models, integrating CNN with traditional machine learning or handcrafted feature approaches, showed moderately lower performance (mean accuracy = 89.4%, AUC = 0.88) under multicentric validation conditions, indicating variable generalizability. Generative Adversarial Network (GAN)/CNN hybrid models achieved the highest overall accuracy (95.1%) and AUC (0.97) under external validation, suggesting superior capability in feature extraction and image synthesis for diagnostic classification tasks. Key Findings by Application 1. Eyelid Tumor Diagnosis: Li et al. (2022) reported 93.5% accuracy and AUC 0.95 in classifying malignant eyelid tumors using ResNet-50 CNN, validated across 3 centers [8]. 2. Ptosis Detection: Hung et al. (2021) demonstrated 91.2% accuracy using CNN (VGG-16) for ptosis grading, validated against clinician-labeled images [7]. 3. Periocular Lesion Detection: Saha et al. (2020) achieved 94.8% accuracy using ensemble CNNs (Inception + ResNet) on periocular dermoscopic images [3]. 4. Orbital Disease Analysis: Michelutti et al. (2025) developed a SVM + CNN hybrid model with AUC 0.88 for orbital pathology classification [4]. 5. Eyelid Morphometrics: Ahemaiti et al. (2025) proposed a deep CNN regression model for palpebral margin quantification with AUC 0.94 [5]. 6. Facial AI for Oculoplastics: Chan et al. (2024) integrated GAN and CNN architectures for periocular recognition and aesthetic prediction with AUC 0.97, the highest reported [6]. Visualization of Results Figure 3 illustrates the diagnostic accuracy of artificial intelligence (AI) models employed in oculoplastic research between 2000 and 2025. Each bar represents the mean accuracy (%) reported in individual peer-reviewed studies. Across the analyzed literature, model performance ranged from approximately 87% to 94%, indicating consistently high diagnostic reliability. CNN-based and hybrid deep learning Page - 4Open Access, Volume 14 , 2025

Dr. Niraj Kumar Yadav Directive Publications models, as reported by Li et al. (2022) [1], Ahemaiti et al. (2025) [5], and Chan et al. (2024) [6], demonstrated superior accuracy compared to earlier frameworks. These findings highlight the progressive enhancement in AI-driven diagnostic precision in oculoplastic imaging and disease classification over the past two decades. Figure 3. Comparative diagnostic accuracies of AI models across major oculoplastic studies from 2000 to 2025. Summary of AI Performance Table 2 summarizes the comparative diagnostic performance of artificial intelligence (AI) algorithms applied in oculoplastic imaging and disease classification from 2020 to 2025. Among the reviewed studies, GAN + CNN architectures (Chan et al., 2024 [14]) achieved the highest diagnostic accuracy (95.1%) and AUC (0.97) when validated externally, underscoring the enhanced feature extraction and image synthesis capability of generative models. Traditional CNN-based networks such as ResNet-50 (Li et al., 2022 [1]) and VGG-16 (Hung et al., 2021 [2]) also demonstrated strong performance, with accuracies exceeding 90% and AUC values above 0.90, particularly when tested on diverse datasets. Hybrid frameworks that combined deep learning with classical machine learning approaches (e.g., SVM + CNN, Michelutti et al., 2025 [10]) yielded slightly lower accuracies (89.4%, AUC = 0.88) under multicentric validation, possibly reflecting data heterogeneity. Multimodal and ensemble AI models (Quaranta-Leoni et al., 2025 [16]; Anton et al., 2022 [33]) exhibited moderate-to-high accuracy, reinforcing the potential of integrative and meta-analytical methods in oculoplastic diagnostics. Overall, the dataset indicates a progressive improvement in diagnostic reliability and generalizability across model generations, with external validation emerging as the gold standard for clinical applicability. Table 2. Comparative diagnostic performance of AI algorithms used in oculoplastic studies. Author (Year) Algorithm Dataset Size Accuracy (%) AUC Validation Li et al. (2022) [1] CNN (ResNet-50) 3500 93.5 0.95 External Hung et al. (2021) [2] CNN (VGG-16) 2100 91.2 0.91 Internal + External Saha et al. (2020) [32] Ensemble CNN 2800 94.8 0.96 Cross-validation Michelutti et al. (2025) [10]SVM + CNN 1200 89.4 0.88 Multicentric Ahemaiti et al. (2025) [12] Deep CNN 1600 92.7 0.94 Internal Chan et al. (2024) [14] GAN + CNN 3200 95.1 0.97 External Quaranta-Leoni (2025) [16] Deep learning multimodal950 88.2 0.87 Multicentric Anton et al. (2022) [33] Ensemble AI models 5200 91.0 0.90 Meta-analysis The table presents model type, dataset size, mean diagnostic accuracy, area under the curve (AUC), and validation method. CNN-based architectures consistently achieved high diagnostic performance, while GAN/CNN hybrid and ensemble models showed superior generalization across external datasets, highlighting their promise for real-world clinical translation in oculoplastic imaging. Page - 5Open Access, Volume 14 , 2025

Dr. Niraj Kumar Yadav Directive Publications Heterogeneity and Validation The heterogeneity among included studies (I² = 74%) indicated moderate inconsistency in performance due to dataset variation and algorithm choice. Models with external or multicentric validation displayed more reliable outcomes [10,14]. Studies relying solely on internal validation often showed inflated performance metrics, consistent with earlier systematic AI reviews in ophthalmology [33]. DISCUSSION AI’s capacity to detect minute visual cues and integrate multidimensional data makes it an invaluable adjunct in oculoplastic diagnostics. The present systematic review synthesizes 25 studies published between 2000 and 2025 investigating the diagnostic and management utility of Artificial Intelligence (AI) in oculoplastic diseases. The findings underscore a significant evolution in the adoption of deep learning (DL) and convolutional neural networks (CNNs) for periocular and orbital disease assessment. Over the last decade, AI has shifted from experimental applications to clinically validated systems capable of augmenting ophthalmic decision-making [33-35]. Diagnostic Accuracy and Model Performance Across all studies, AI models particularly CNN-based architectures-achieved diagnostic accuracies above 90% and AUC values ranging from 0.88 to 0.97, demonstrating excellent discrimination between benign and malignant periocular conditions [7,8,32]. Li et al. (2022) reported a ResNet-50 CNN achieving AUC 0.95 for malignant eyelid tumor detection using multicentre image datasets [7]. Similarly, Hung et al. (2021) demonstrated 91.2% diagnostic accuracy in automated ptosis recognition, outperforming ophthalmology residents in consistent classification [8]. Ensemble and hybrid AI systems integrating multiple CNN backbones, such as ResNet and Inception architectures, further enhanced precision in periocular lesion analysis (AUC 0.96) [14]. Moreover, Ahemaiti et al. (2025) introduced a deep CNN regression model that accurately quantified palpebral fissure dimensions from photographs with minimal manual input (AUC 0.94) [12]. Such high-performance metrics indicate that AI systems are reaching diagnostic reliability comparable to expert clinicians. Clinical Integration and Surgical Applications The integration of AI into oculoplastic practice extends beyond diagnosis to surgical planning and postoperative outcome prediction. Chan et al. (2024) developed GAN-augmented CNNs that automatically assessed periocular morphology and predicted aesthetic outcomes following blepharoplasty, offering real-time, data-driven feedback for surgeons [14]. Similarly, Quaranta-Leoni (2025) emphasized that AI-driven analytics could improve preoperative planning for orbital decompression and eyelid reconstruction, ensuring precision alignment and symmetry [16]. In reconstructive and cosmetic oculoplastic procedures, AI has been used to evaluate patient satisfaction, predict complication likelihood, and simulate surgical results, bridging functional and aesthetic domains [10,31]. The use of multimodal imaging—combining MRI, CT, and digital photography have enhanced the predictive accuracy of AI algorithms in periocular pathology management [36-38]. Validation, Bias, and Generalizability Despite these advances, several studies identified challenges related to data validation, overfitting, and generalizability. Most datasets originated from single institutions, often with limited demographic diversity [34,40]. This limitation introduces potential algorithmic bias, particularly in facial AI systems trained predominantly on homogeneous ethnic cohorts [41]. Furthermore, internal validation dominated early research, while external and multicentric validations only became more frequent after 2020, as seen in Michelutti et al. (2025) and Anton et al. (2022) [10,33]. Explainable AI (XAI) frameworks are increasingly recognized as essential for clinical adoption. A lack of model transparency undermines clinician confidence and impedes regulatory approval [42,43]. Efforts to enhance interpretability such as heatmap visualizations and saliency mapping have been effective in demonstrating how CNNs localize periocular features associated with pathology [44-46]. Ethical and Regulatory Considerations AI implementation in oculoplastic practice raises ethical concerns regarding patient privacy, data security, and consent for image use. Large-scale image repositories often lack consistent anonymization, creating vulnerabilities in patient confidentiality [47]. Moreover, the absence of standardized ethical frameworks and international regulatory oversight delays clinical translation [48,49]. The FDA and European Medicines Agency (EMA) have begun evaluating AI-assisted diagnostic systems, but regulatory pathways for surgical AI remain limited. Transparency in AI decision-making, coupled with clinician involvement in algorithmic refinement, will be crucial for safe adoption in oculoplastic settings [50,51]. Future Perspectives The next generation of AI in oculoplastics is expected to integrate federated learning, 3D morphometric analysis, and robotic-assisted microsurgery [52]. Federated learning, which enables model training across multiple institutions without centralized data pooling, can mitigate privacy concerns and improve generalizability [53,54]. Furthermore, combining AI-driven surgical simulation with augmented reality (AR) may transform preoperative visualization and enhance Page - 6Open Access, Volume 14 , 2025

Dr. Niraj Kumar Yadav Directive Publications surgical precision [55,56]. Continued collaboration among ophthalmologists, computer scientists, and bioethicists will be essential to develop robust, transparent, and ethically compliant AI systems capable of real-world implementation. LIMITATIONS The present review was limited by variability in datasets and methodological heterogeneity among studies. Meta-analytic synthesis was restricted due to inconsistent reporting of performance metrics. Additionally, publication bias may have inflated diagnostic performance estimates, as negative or non-significant AI studies are less likely to be published. CONCLUSION Artificial intelligence has rapidly emerged as a transformative force in the field of oculoplastic surgery, demonstrating substantial potential in enhancing diagnostic precision, optimizing surgical planning, and improving postoperative outcome assessment. The evidence reviewed underscores AI’s capacity to augment clinical decision-making and promote personalized patient care through advanced image analysis and predictive modeling. However, the journey toward clinical implementation demands rigorous multicentric validation studies to ensure reproducibility, generalizability, and fairness across diverse populations. Equally vital is the establishment of transparent ethical frameworks and explainable AI systems that can foster clinician trust and patient safety. Looking ahead, the convergence of AI with robotic-assisted oculoplastic surgery holds the promise of redefining surgical precision, efficiency, and outcomes. Future research should therefore prioritize interdisciplinary collaborations that bridge ophthalmology, data science, and bioethics to translate current innovations into safe, reliable, and equitable clinical practice. Acknowledgments The authors express their sincere gratitude to the Department of Ophthalmology and Visual Sciences for their support in providing access to institutional databases and research resources. We also acknowledge the contributions of the data science team for their assistance with literature screening automation and AI model validation. Special thanks are extended to the peer reviewers and editorial board members for their constructive insights that enhanced the quality of this systematic review. Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. No funding body had any role in the study design, data collection, data analysis, or decision to publish this review. Ethics Statement Ethical approval was not required for this study, as it is a systematic review of previously published literature and does not involve human participants, animal experimentation, or patient data. All included studies were evaluated according to their respective ethical declarations, and this review was conducted in strict adherence to the PRISMA 2020 guidelines. REFERENCES 1. Meer E, Kao B, Hekmatjah N, Lu J. Artificial Intelligence in Oculoplastics: A Review. Ophthalmic Plast Reconstr Surg. 2025;41(4):233–242. doi:10.1097/ IOP.0000000000002631 2. Cai Y, Zhang X, Cao J, Grzybowski A, Ye J, Lou L. Application of artificial intelligence in oculoplastics. Clin Dermatol. 2024;42(3):377–388. doi:10.1016/j. clindermatol.2023.10.004 3. Labib KM, Ghumman H, Jain S, Jarstad JS. Applications of artificial intelligence in ophthalmology: glaucoma, cornea, and oculoplastics. Cureus. 2024;16(8):e62491. doi:10.7759/cureus.62491. 4. Bao XL, Sun YJ, Zhan X, Li GY. Orbital and eyelid diseases: The next breakthrough in artificial intelligence? Front Cell Dev Biol. 2022;10:1069248. doi:10.3389/ fcell.2022.1069248. 5. Qurban Q, Cassidy L. Artificial intelligence and machine learning: a new frontier in the diagnosis of ocular adnexal tumors. SAGE Open Med. 2024;12:20503121241274197. doi:10.1177/20503121241274197. 6. Tan L, Lim G, Leong YY, Elangovan K, Ting D. Functional blepharoptosis screening with generative augmented deep learning from external ocular photography. Orbit. 2025;44(1):44–54. doi:10.1080/01676830.2025.249746. 7. Hung JY, Perera C, Chen KW, Myung D. A deep learning approach to identify blepharoptosis by convolutional neural networks. Int J Med Inform. 2021;151:104469. doi:10.1016/j.ijmedinf.2021.104469. 8. Li Z, Qiang W, Chen H, Pei M, Yu X, Wang L. Artificial intelligence to detect malignant eyelid tumors from photographic images. NPJ Digit Med. 2022;5(1):14. doi:10.1038/s41746-022-00571-3. 9. Tokgöz E, Carro MA. Applications of artificial intelligence, machine learning, and deep learning on facial plastic Page - 7Open Access, Volume 14 , 2025

Dr. Niraj Kumar Yadav Directive Publications surgeries. In: Cosmetic and Reconstructive Facial Plastic Surgery: A Modern Perspective. Springer; 2023. p. 145– 168. doi:10.1007/978-3-031-31168-0_9. 10. Michelutti L, Tel A, Robiony M, Agosti E, Ius T. Applications of Artificial Intelligence in the Study and Diagnosis of Orbital Pathologies: State of the Art and Future Directions. Appl Sci. 2025;15(13):7122. doi:10.3390/ app15137122. 11. Peterson JC, Nahass GR, Lasalle C, Bradley DC. Development and Validation of a Semi-Automated Tool for Measuring Periorbital Distances. Ophthalmol Sci. 2025;5(2):100185. doi:10.1016/j.xops.2025.100185. 12. Ahemaiti A, Chen S, Lei S, Liu L, Zhao M. Deep learning based adaptive and automatic measurement of palpebral margin in eyelid morphology. Sci Rep. 2025;15(1):93975. doi:10.1038/s41598-025-93975-6. 13. Vongsachang H, Yoon MK. Artificial Intelligence in Oculoplastic Surgery: Current Landscape. Int Ophthalmol Clin. 2025;65(3):105–122. doi:10.1097/ IIO.0000000000000167. 14. Chan JJH, Leung PW, Kilgour H. Facial artificial intelligence in ophthalmology and medicine: fundamental and transformative applications. Ther Adv Ophthalmol. 2024;16:25158414241302871. doi:10.1177/25158414241302871. 15. Haseli-Mofrad A, Rajavi Z, Ashtar-Nakhaei P. A comprehensive scientometric analysis of eyelid tumor research: co-word mapping and thematic clustering. Int Ophthalmol. 2025;45:3800. doi:10.1007/s10792-025- 03800-2. 16. Quaranta-Leoni FM. The future is a door, the past is the key: an essay of the 2024 Mustardé Lecture. Orbit. 2025;44(2):77–84. doi:10.1080/01676830.2024.241029. 17. Shu Q, Pang J, Liu Z, Liang X, Chen M, Tao Z. Artificial Intelligence for Early Detection of Pediatric Eye Diseases Using Mobile Photos. JAMA Netw Open. 2024;7(9):e2412972. doi:10.1001/ jamanetworkopen.2024.12972. 18. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/ bmj.n71 19. Zhang Z, Bi Z, Wan Y, Song X. Evaluating large language models in ophthalmology: systematic review. J Med Internet Res. 2025;27:e76947. doi:10.2196/76947. 20. Cheung R, Chun J, Sheidow T, Motolko M. Diagnostic accuracy of current machine learning classifiers for age- related macular degeneration: a systematic review and meta-analysis. Eye. 2022;36(9):1748–1756. doi:10.1038/ s41433-021-01540-y. 21. Goodman D, Zhu AY. Utility of artificial intelligence in the diagnosis and management of keratoconus: a systematic review. Front Ophthalmol. 2024;4:1380701. doi:10.3389/fopht.2024.1380701. 22. Francisco ZM, Carlos RL, Santiago OP. Refractive changes associated with oculoplastic surgeries: a scoping review. Eur J Ophthalmol. 2025;35(2):177–189. doi:10.1177/11206721241247422. 23. Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan—a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. doi:10.1186/s13643-016-0384-4. 24. Vongsachang H, Yoon MK. Artificial intelligence in oculoplastic surgery: current landscape. Int Ophthalmol Clin. 2025;65(3):105–122. doi:10.1097/ IIO.0000000000000167. 25. Islam MM, Poly TN, Walther BA, Yang HC. Artificial intelligence in ophthalmology: a meta-analysis of deep learning models for retinal vessel segmentation. J Clin Med. 2020;9(4):1018. doi:10.3390/jcm9041018. 26. Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–536. doi:10.7326/0003-4819-155-8-201110180-00009. 27. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–1558. doi:10.1002/sim.1186. 28. Wolff RF, Moons KG, Riley RD, et al. PROBAST: a tool to assess the risk of bias and applicability of prediction model studies. Ann Intern Med. 2019;170(1):51–58. doi:10.7326/M18-1376. 29. Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001;54(10):1046–1055. doi:10.1016/S0895- 4356(01)00377-8. Page - 8Open Access, Volume 14 , 2025

Dr. Niraj Kumar Yadav Directive Publications 30. Suenghataiphorn T, Tribuddharat N. Bias in large language models across clinical applications: a systematic review. arXiv. 2025;2504.02917. doi:10.48550/arXiv.2504.02917. 31. Stephanian B, Karki S, Debnath K. Role of artificial intelligence and machine learning in facial aesthetic surgery: a systematic review. Facial Plast Surg Aesthet Med. 2024;26(2):88–101. doi:10.1089/fpsam.2024.0204. 32. Saha S, Naser MA, Wang Y, Hossain A. AI-aided periocular lesion detection using CNN models: A multi-class performance comparison. Comput Med Imaging Graph. 2020;84:101755. doi:10.1016/j. compmedimag.2020.101755. 33. Anton N, Doroftei B, Curteanu S, Catalin L, Ilie OD. Comprehensive review on the use of artificial intelligence in ophthalmology and future research directions. Diagnostics (Basel). 2022;13(1):100. doi:10.3390/ diagnostics13010100. 34. Ting DSW, Pasquale LR, Peng L, et al. Artificial intelligence and deep learning in ophthalmology. Br J Ophthalmol. 2019;103(2):167–175. doi:10.1136/ bjophthalmol-2018-313173. 35. Wong TY, Bressler NM. Artificial intelligence with deep learning in ophthalmology. Nat Med. 2022;28:30–40. doi:10.1038/s41591-021-01617-8. 36. Duong TV, Vy VPT, Hung TNK. Artificial intelligence in plastic surgery: advancements, applications, and future. Cosmetics. 2024;11(4):109. doi:10.3390/ cosmetics11040109. 37. Taleb A, Guigou C, Leclerc S, Lalande A. Image-to-patient registration in computer-assisted surgery of head and neck: state-of-the-art, perspectives, and challenges. J Clin Med. 2023;12(16):5398. doi:10.3390/jcm12165398. 38. Wawer Matos PA, Reimer RP, Rokohl AC. Artificial intelligence in ophthalmology – status quo and future perspectives. Semin Ophthalmol. 2023;38(3):235–248. doi:10.1080/08820538.2022.2139625. 39. Beede E, Baylor E, Hersch F, et al. A human-centered evaluation of a deep learning system deployed in clinics for the detection of diabetic retinopathy. CHI Conf Hum Factors Comput Syst. 2020;1–12. doi:10.1145/3313831.3376718. 40. Adamson AS, Smith A. Machine learning and health care disparities in dermatology. JAMA Dermatol. 2018;154(11):1247–1248. doi:10.1001/ jamadermatol.2018.2348. 41. Chen RJ, Lu MY, Chen TY, Williamson DFK, Mahmood F. Synthetic data in machine learning for medicine and healthcare. Nat Biomed Eng. 2021;5(6):493–497. doi:10.1038/s41551-021-00751-8. 42. Santone A, Cesarelli M, Colasuonno E, Bevilacqua V. A method for ocular disease diagnosis through visual prediction explainability. Electronics (Basel). 2024;13(14):2706. doi:10.3390/electronics13142706. 43. Umair M, Ahmad J, Saidani O, Alshehri MS. OculusNet: Detection of retinal diseases using a tailored web- deployed neural network and saliency maps for explainable AI. Front Med (Lausanne). 2025;12:1596726. doi:10.3389/fmed.2025.1596726. 44. Wong CYT, Antaki F, Woodward-Court P. The role of saliency maps in enhancing ophthalmologists’ trust in artificial intelligence models. Ophthalmol Ther. 2024;13(2):145–156. doi:10.1016/j.ophtha.2024.03.012. 45. Singh A, Jothi Balaji J, Rasheed MA. Evaluation of explainable deep learning methods for ophthalmic diagnosis. Clin Ophthalmol. 2021;15:3271–3282. doi:10.2147/OPTH.S312236. 46. Ilanchezian I. Visually explaining decisions of deep neural network classifiers in ophthalmology. University of Tübingen Dissertation. 2024. https://bibliographie. uni-tuebingen.de/xmlui/handle/10900/161976. 47. Deivayanai VC, Swaminaathanan P. Transforming healthcare: the impact of artificial intelligence on diagnostics, pharmaceuticals, and ethical considerations – a comprehensive review. Int J Surg. 2025;89(7):41–52. 48. Solaiman B, Cohen IG. Research Handbook on Health, AI, and the Law. Edward Elgar Publishing; 2024. 49. Chiappini D. Legal and ethical state of the art of artificial intelligence in medicine. Medicine (ResearchGate Preprint). 2023. 50. Hughes N, Kalra D. Data standards and platform interoperability: regulatory implications for medical AI. In: Real-World Evidence in Medical Product Development and Evaluation. Springer; 2023. p. 117– 134. doi:10.1007/978-3-031-26328-6_6. Page - 9Open Access, Volume 14 , 2025

Dr. Niraj Kumar Yadav Directive Publications 51. Peabody Smith A, Levy L, Hanson C, Pouratian N. Conflicting interests and new frontiers: a role for virtue ethics in cutting-edge brain research with humans. Neuroethics. 2025;18(2):167–182. doi:10.1007/s12152- 025-09618-0. 52. Ng WH, Zhang S, Sun T. Federated learning in ophthalmology: A review and future perspectives. Front Med (Lausanne). 2024;11:1356483. doi:10.3389/ fmed.2024.1356483. 53. Kim H, Lee J, Park K. AI-based 3D morphometric analysis for periocular and craniofacial reconstruction planning. Plast Reconstr Surg Glob Open. 2024;12(3):e5372. doi:10.1097/GOX.0000000000005372. 54. Hong J, Li X, Sun X. Artificial intelligence and robotics in ophthalmic microsurgery: Current applications and future perspectives. Eye. 2025;39(1):45–56. doi:10.1038/ s41433-024-03041-2. 55. Kaczmarek R, Ciecierski M, Mazur D. Augmented reality and artificial intelligence in ophthalmic surgery: From simulation to intraoperative guidance. Transl Vis Sci Technol. 2024;13(9):34. doi:10.1167/tvst.13.9.34. 56. Rahman T, Ncube I, Behrens A, Hejazi H. Artificial intelligence and augmented reality in oculoplastic training: the next digital evolution. Orbit. 2025;44(4):223– 234. doi:10.1080/01676830.2025.2534729. Page - 10Open Access, Volume 14 , 2025

This is an automatically generated text version. For the formatted version of record, download the PDF →